The Methodist Hospital Research Institute

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant

First Posted Date
2020-12-11
Last Posted Date
2020-12-11
Lead Sponsor
The Methodist Hospital Research Institute
Registration Number
NCT04665310

68 Ga-PSMA for High Risk Prostate Cancer

Phase 1
Completed
Conditions
Prostate Cancer
High Risk
Interventions
Drug: 68Ga-PSMA
First Posted Date
2020-11-04
Last Posted Date
2023-08-28
Lead Sponsor
The Methodist Hospital Research Institute
Target Recruit Count
80
Registration Number
NCT04614363
Locations
🇺🇸

Houston Methodist, Houston, Texas, United States

Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)

First Posted Date
2020-09-18
Last Posted Date
2020-11-02
Lead Sponsor
The Methodist Hospital Research Institute
Target Recruit Count
350
Registration Number
NCT04554992
Locations
🇺🇸

Houston Methodist Hopsital, Houston, Texas, United States

Blood Flow Restriction Training for The Shoulder

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: Blood flow restriction therapy
First Posted Date
2020-09-07
Last Posted Date
2024-08-09
Lead Sponsor
The Methodist Hospital Research Institute
Target Recruit Count
69
Registration Number
NCT04540367
Locations
🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

Motion Capture: Baseball Swing

First Posted Date
2020-08-06
Last Posted Date
2020-08-27
Lead Sponsor
The Methodist Hospital Research Institute
Target Recruit Count
16
Registration Number
NCT04503070
Locations
🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

Clazakizumab vs. Placebo - COVID-19 Infection

First Posted Date
2020-07-31
Last Posted Date
2020-07-31
Lead Sponsor
The Methodist Hospital Research Institute
Target Recruit Count
60
Registration Number
NCT04494724
Locations
🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

Genetic Mechanism of Conserved Ancestral Haplotype in SCA10

First Posted Date
2020-07-31
Last Posted Date
2021-09-01
Lead Sponsor
The Methodist Hospital Research Institute
Target Recruit Count
100
Registration Number
NCT04495426
Locations
🇧🇷

Universidade Federal do Paraná, Paraná, Curibita, Brazil

🇧🇷

Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil

🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

Effects of Blood Flow Restriction Rehabilitation After Anterior Cruciate Ligament Reconstruction

Not Applicable
Completed
Conditions
ACL Tear
Interventions
Device: Blood flow restriction (BFR)
First Posted Date
2020-07-24
Last Posted Date
2024-11-25
Lead Sponsor
The Methodist Hospital Research Institute
Target Recruit Count
50
Registration Number
NCT04484961

Limb Occlusion Pressure Tourniquets to Decrease Pain After Surgery

Not Applicable
Recruiting
Conditions
Limb Occlusion Pressure
Interventions
Device: Experimental - Limb Occlusion pressure
First Posted Date
2020-05-15
Last Posted Date
2024-10-18
Lead Sponsor
The Methodist Hospital Research Institute
Target Recruit Count
400
Registration Number
NCT04390425
Locations
🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

Intraosseous Morphine in Primary TKA

Phase 4
Completed
Conditions
Knee Disease
Arthritis Knee
Pain, Acute
Interventions
Drug: Morphine
First Posted Date
2020-05-14
Last Posted Date
2021-07-07
Lead Sponsor
The Methodist Hospital Research Institute
Target Recruit Count
48
Registration Number
NCT04388111
Locations
🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy